Completed × Head and Neck Neoplasms × Radiotherapy, Intensity-Modulated × Clear all Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
Phase 3 Completed
987 enrolled 59 charts
De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study
Phase 2 Completed
115 enrolled 18 charts
APA
Phase 2 Completed
96 enrolled 34 charts
De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca
Phase 2 Completed
45 enrolled 22 charts
Pembrolizumab + Radiation for Locally Adv SCC of the Head and Neck (SCCHN) Not Eligible Cisplatin
Phase 2 Completed
29 enrolled 27 charts
Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck
Phase 2 Completed
43 enrolled 16 charts
Postoperative Concurrent Chemoradiotherapy in Treating Patients With High-Risk Salivary Gland Carcinomas
Phase 2 Completed
107 enrolled
P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC
Phase 2 Completed
195 enrolled 19 charts
Radiation + Cisplatin or Panitumumab in Locally Advanced Stage III or Stage IV Head and Neck Cancer
Phase 3 Completed
320 enrolled 13 charts
Feasibility Study of Incorporating 18F-FDG-PET Imaging in Radiotherapy for Head and Neck Cancer
Phase 1 Completed
40 enrolled
Ph 2 Open Label Study of GC4419 to Reduce SOM Associated With Chemoradiotherapy for Head and Neck Cancer
Phase 2 Completed
38 enrolled 10 charts
Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Phase 3 Completed
940 enrolled 19 charts
HICARE
Phase 4 Completed
139 enrolled
INFIELD
Phase 2 Completed
72 enrolled 14 charts
A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer
Phase 1/2 Completed
53 enrolled
A Pilot Trial of Image-Guided Adaptive Radiotherapy for Head and Neck Cancer
Phase NA Completed
25 enrolled 4 charts
Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer
Phase 2 Completed
37 enrolled 6 charts
Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck Cancer
Phase 1/2 Completed
37 enrolled 9 charts
Postoperative Concurrent Chemoradiotherapy With Docetaxel for High-Risk Squamous Cell Carcinoma of Head and Neck
Phase 2 Completed
91 enrolled
Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
Phase 2 Completed
20 enrolled 17 charts
MRI Mapping in Planning Radiation Therapy to the Base of Skull and Brain in Patients With Nonmetastatic Head and Neck Cancer
Completed
3 enrolled
A Study of Prexasertib (LY2606368) With Chemotherapy and Radiation in Participants With Head and Neck Cancer
Phase 1 Completed
70 enrolled
Concurrent Chemotherapy Based on Genetic Testing in Patients With High-Risk Salivary Gland Tumors
Phase 1 Completed
20 enrolled
Cisplatin, Bevacizumab, and Intensity-Modulated Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Phase 2 Completed
44 enrolled 9 charts
SCS-IMRT
Phase NA Completed
106 enrolled
Feasibility of IMRT Modulation to Account for Scattered Radiation From Dental Fillings in Head and Neck Cancer
Phase NA Completed
30 enrolled 10 charts
DREXNECK
Phase 2 Completed
1 enrolled
Weekly Nanoparticle Albumin-Bound Paclitaxel (Abraxane) + Weekly Cetuximab + Radiation Therapy (IMRT, Intensity-Modulated Radiation Therapy) in Patients With Stage III-IVB Head and Neck Squamous Cell Carcinoma (HNSCC)
Phase 1 Completed
25 enrolled
Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCC
Phase 2 Completed
40 enrolled
Using Intensity-Modulated Radiation Therapy to Permit Sparing of Parotid Gland Function
Phase 1/2 Completed
130 enrolled
Side Effects of High-Dose Intensity-Modulated Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
Completed
20 enrolled
Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity - Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck Cancer
Phase 2 Completed
14 enrolled 6 charts
Radiation Therapy (IMRT) + RAD001 (Everolimus) + Cisplatin for Patients With Head and Neck Cancer
Phase 1 Completed
13 enrolled
Bortezomib, Cetuximab, and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage IV Head and Neck Cancer
Phase 1 Completed
46 enrolled
PET Scans in Patients With Head And Neck Cancer Who Are Undergoing 3-Dimensional Conformal Radiation Therapy And Intensity-Modulated Radiation Therapy
Phase NA Completed
40 enrolled